Circulating Betatrophin Levels Are Increased in Patients With Type 2 Diabetes and Associated With Insulin Resistance
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
CONTEXT: Betatrophin has recently attracted increasing interests as a potential β-cell regenerative therapy in diabetes. However, differences in betatrophin profiles in patients with type 2 diabetes mellitus (T2DM) remain unclear. OBJECTIVE: The objective of the study was to examine circulating betatrophin levels in subjects with different glucose tolerance status and its correlation with insulin resistance. DESIGN, SETTING, AND PARTICIPANTS: Serum betatrophin levels were measured using an ELISA in age-, sex-, body mass index-, and blood lipid-matched subjects with normal glucose tolerance (n = 137), isolated impaired fasting glucose (n = 69), isolated impaired glucose tolerance (n = 120), and newly diagnosed T2DM (n = 112) from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal study. RESULTS: Serum betatrophin levels were elevated in patients with T2DM compared with subjects with normal glucose tolerance, isolated impaired fasting glucose, or isolated impaired glucose tolerance (798.6 ± 42.5 vs 692.7 ± 29.0, P < .05, vs 682.7 ± 43.0, P < .05, vs 646.8 ± 34.3 pg/mL, P < .01). Betatrophin levels positively correlated with the index of homeostasis model assessment of insulin resistance (partial r = 0.11); inversely correlated with quantitative insulin sensitivity check index (partial r = -0.11), the Gutt insulin sensitivity index (partial r = -0.12), and the Matsuda insulin sensitivity index (partial r = -0.11) after controlling for age, sex, body mass index, and blood lipid in all participants (all values of P < .05). CONCLUSION: Circulating betatrophin levels are increased in patients with T2DM and associated with indexes of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is substantiated by the fact that betatrophin levels are higher in T2DM patients,182, 183, 184 although they were lower in one study.185”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [183]
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Atypical angiopoietin-like protein that regulates ANGPTL3
Quagliarini, F., Wang, Y., Kozlitina, J., Grishin, N. V., Hyde, R., Boerwinkle, E., Valenzuela, D. M., Murphy, A. J., Cohen, J. C., & Hobbs, H. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217552109 · Cited by 409
Wang, Y., Quagliarini, F., Gusarova, V., Gromada, J., Valenzuela, D. M., Cohen, J. C., & Hobbs, H. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315292110 · Cited by 317
Zhang, R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.038 · Cited by 311
Ren, G., Kim, J. Y., & Smas, C. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00084.2012 · Cited by 261
Evaluation of insulin sensitivity in clinical practice and in research settings
Monzillo, L. U., & Hamdy, O. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.dec.397-412 · Cited by 259
Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
Fu, Z., Berhane, F., Fite, A., Seyoum, B., Abou-Samra, A. B., & Zhang, R. (2014) · Scientific Reports · doi:10.1038/srep05013 · Cited by 232
Fenzl, A., Itariu, B. K., Kosi, L., Fritzer-Szekeres, M., Kautzky-Willer, A., Stulnig, T. M., & Kiefer, F. W. (2014) · Diabetologia · doi:10.1007/s00125-014-3208-x · Cited by 165
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
Zhang, R. (2016) · Open Biology · doi:10.1098/rsob.150272 · Cited by 219
Chung, H. S., Lee, M. J., Hwang, S. Y., Lee, H. J., Yoo, H. J., Seo, J.-A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0324-y · Cited by 129
“observed that ANGPTL8 levels were positively correlated with insulin resistance indexes including HOMAIR [18].”
BackgroundInfluentialLee, Y., Lee, S., Lee, C. J., Kim, S. H., Song, Y.-M., Yoon, M. R., Jeon, B. H., Lee, J. H., Lee, B., Kang, E. S., et al. (2016) · Scientific Reports · doi:10.1038/srep24013 · Cited by 120
ANGPTL8: An Important Regulator in Metabolic Disorders
Luo, M., & Peng, D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00169 · Cited by 83
“The association of ANGPTL8 with insulin resistance (32, 33, 41), glucose (32, 34), C-peptide, and glycosylated hemoglobin (HbA1C) (37) were also contentious.”
BackgroundCirculating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training
Abu-Farha, M., Sriraman, D., Cherian, P., AlKhairi, I., Elkum, N., Behbehani, K., & Abubaker, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147367 · Cited by 86
“Type 2 Diabetes (T2D) is caused by the inability of β-cells to compensate for insulin resistance leading to uncontrolled hyperglycemia [1,2,3].”
InfluentialFu, Z., Abou-Samra, A. B., & Zhang, R. (2015) · Scientific Reports · doi:10.1038/srep18502 · Cited by 82
Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin
Nidhina Haridas, P. A., Soronen, J., Sädevirta, S., Mysore, R., Quagliarini, F., Pasternack, A., Metso, J., Perttilä, J., Leivonen, M., Smas, C. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1254 · Cited by 75
“measured in several studies and suggested to be biomarkers for both type 2 (14–17, 36) and type 1 (37) diabetes, obesity (36), hypercholesterolemia (18), as well as insulin resistance (17).”
MethodANGPTL8 (betatrophin) role in diabetes and metabolic diseases
Abu‐Farha, M., Abubaker, J. A., & Tuomilehto, J. O. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2919 · Cited by 73
“The ANGPTL8 level in people with T2D was the highest among all groups and associated with insulin resistance indices.(56) A Japanese study comprising 12 healthy controls, 34 people with T1D, and 30 people with T2D showed that ANGPTL8 was higher in both T1D and T2D subjects than in non‐diabetic controls.”
BackgroundResultCox, A. R., Lam, C. J., Bonnyman, C. W., Chavez, J., Rios, J. S., & Kushner, J. A. (2015) · Diabetologia · doi:10.1007/s00125-015-3590-z · Cited by 66
Chen, C.-C., Susanto, H., Chuang, W.-H., Liu, T.-Y., & Wang, C.-H. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0326-9 · Cited by 61
“A number of studies reported that betatrophin was increased in T2DM patients [4, 8, 12], while Gomez-Ambrosi et al.”
BackgroundCrujeiras, A. B., Zulet, M. Á., Abete, I., Amil, M., Carreira, M. C., Martínez, J. A., & Casanueva, F. F. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.206 · Cited by 53
Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women
Barja-Fernández, S., Folgueira, C., Seoane, L. M., Casanueva, F. F., Diéguez, C., Castelao, C., Agüera, Z., Baños, R., Botella, C., de la Torre, R., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1595 · Cited by 53
“While increased plasma betatrophin levels were found in type 1 diabetic patients (22) and in type 2 diabetic patients with (21, 23) or without obesity (24, 25), others found that its levels were not modified in obese humans (19) or decreased in human obesity and type 2 diabetes (26).”
BackgroundElevated circulating levels of betatrophin are associated with polycystic ovary syndrome
Çalan, M., Yılmaz, Ö., Küme, T., Kocabaş, G. Ü., Senses, P. Y., Senses, Y. M., Temür, M., & Çalan, Ö. G. (2016) · Endocrine · doi:10.1007/s12020-016-0875-z · Cited by 51
Wang, H., Lai, Y., Han, C., Liu, A., Fan, C., Wang, H., Zhang, H., Ding, S., Teng, W., & Shan, Z. (2016) · Scientific Reports · doi:10.1038/srep28431 · Cited by 53
Self-citationGómez‐Ambrosi, J., Corrales, E. P., Catalán, V., Rodríguez, A., Ramírez, B., Romero, S., Vila, N., Ibáñez, P., Margall, M. A., Silva, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2084 · Cited by 48
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0
Ruszała, M., Pilszyk, A., Niebrzydowska-Tatus, M., Kimber-Trojnar, Ż., Trojnar, M. P., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084364 · Cited by 44
“It also appears to be associated with the development of type 1 diabetes [61], T2DM [70], hypertension, and metabolic syndrome [69].”
BackgroundEvaluation of circulating betatrophin levels in gestational diabetes mellitus
Erol, O. Ö., Ellidağ, H. Y., Ayık, H., Özel, M. K., Derbent, A. U., & Yılmaz, N. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056142 · Cited by 43
“[17] observed a positive correlation between serum betatrophin levels and indices of insulin resistance, and a negative correlation between total and HDL-cholesterol in patients with type 2 DM.”
BackgroundResultInsulin upregulates betatrophin expression via PI3K/Akt pathway
Lu, P., Chen, X., Zhang, Z., Zhang, J., Yang, Y., Liu, Z., Xie, J., Shao, S., Zhou, X., Hu, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06052-y · Cited by 42
Self-citationCirculating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
Li, S., Liu, D., Li, L., Li, Y., Li, Q., An, Z., Sun, X., & Tian, H. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6194750 · Cited by 41
“Only two studies analyzed the correlation between betatrophin and postprandial glucose, and both showed a significant positive correlation [14, 15].”
BackgroundIncreased Maternal and Cord Blood Betatrophin in Gestational Diabetes
Wawrusiewicz‐Kurylonek, N., Telejko, B., Kuźmicki, M., Sobota, A., Lipińska, D., Pliszka, J., Raczkowska, B. A., Kuć, P., Urban, R., Szamatowicz, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131171 · Cited by 43
Wang, L., Song, J., Wang, C., Lin, P., Liang, K., Sun, Y., He, T., Li, W., Zhao, R., Qin, J., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2616539 · Cited by 38
“[17] were higher than those of ours despite the similar trends between T2DM and control subjects.”
BackgroundResultFu, J., Hou, C., Li, L., Feng, D., Li, G., Li, M., Li, C., Gao, S., & Li, M. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0461-y · Cited by 36
“For instance, betatrophin levels were variable in type 2 diabetes mellitus (T2DM), either increased [11–14, 23] or decreased [15, 22], and similar patterns were observed in obesity [13, 15, 17–20] and IR [10–12, 15, 21, 22].”
BackgroundResultInfluentialZheng, T., Ge, B., Liu, H., Chen, B., Qin, L., Xiao, L., & Song, J. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0687-y · Cited by 38
Martinez-Perez, B., Ejarque, M., Gutiérrez, C., Núñez‐Roa, C., Roche, K., Vila‐Bedmar, R., Ballesteros, M., Redondo‐Angulo, I., Planavila, A., Villarroya, F., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.012 · Cited by 34
Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes
Huang, Y., Chen, X., Chen, X. N., Feng, Y. Y., Guo, H., Li, S., Ting, D., Jiang, R., Zhang, X., Fang, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4505-y · Cited by 34
Self-citationYi, M., Chen, R., Yang, R., Guo, X., Zhang, J.-C., & Chen, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/479157 · Cited by 38
“These findings corroborate several studies [7, 17, 20, 21] but contradict data reported by GómezAmbrosi et al.”
ResultSelf-citationANGPTL8 in metabolic homeostasis: more friend than foe?
Guo, C. Y., Wang, C., Deng, X., He, J., Yang, L., & Yuan, G. (2021) · Open Biology · doi:10.1098/rsob.210106 · Cited by 31
“Moreover, more detailed data analysis showed that ANGPTL8 was significantly correlated with insulin resistance [9,29], fasting blood glucose [35], postprandial blood glucose [36] and glycosylated haemoglobin (HbA1c) [37], which theoretically supported the association between ANGPTL8 and T2DM.”
Self-citationRelationship of betatrophin with youth onset type 2 diabetes among Asian Indians
Gokulakrishnan, K., Manokaran, K., Pandey, G. K., Amutha, A., Ranjani, H., Anjana, R. M., & Mohan, V. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.028 · Cited by 33
“[38] Chen X, Lu P, He W, Zhang J, Liu L, Yang Y, et al.”
BackgroundMicroRNA-221-3p Regulates Angiopoietin-Like 8 (ANGPTL8) Expression in Adipocytes
Mysore, R., Ortega, F. J., Latorre, J., Ahonen, M. A., Savolainen-Peltonen, H. M., Fischer‐Posovszky, P., Wabitsch, M., Olkkonen, V. M., Fernández‐Real, J. M., & Haridas, P. A. N. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00453 · Cited by 29
Sun, L., Liu, T., Li, L., Tang, W., Zou, J., Chen, X., Zheng, J., Jiang, B., & Shi, Y. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2914 · Cited by 31
“Pro-inflammatory cytokines can cause impaired function, and ultimately the cell death of islets by apoptosis or necrosis in T1D, and inflammation may participate in the pathogenesis of T2D (35).”
InfluentialSelf-citationANGPTL8 enhances insulin sensitivity by directly activating insulin-mediated AKT phosphorylation
Zhang, Z., Wu, H., Dai, L., Yuan, Y., Zhu, Y., Ma, Z., Ruan, X., & Guo, X. (2020) · Gene · doi:10.1016/j.gene.2020.144707 · Cited by 27
The Relationship between Betatrophin Levels in Blood and T2DM: A Systematic Review and Meta-Analysis
Yue, S., Wu, J., Zhang, J., Liu, L., & Chen, L. (2016) · Disease Markers · doi:10.1155/2016/9391837 · Cited by 27
“Study or subgroup Experimental Total Control SD Total Weight Mean difference IV, random, 95% CI Mean difference IV, random, 95% CIMeanMean SD −50−100 Favours [experimental] 50 Favours [control] 1000 Chen et al. 2015 798.6 449.78 112 692.7 339.44 137 12.4% 105.90 [5.06, 206.74] Espes et al. 2014 893 415.69 27 639 280.0…”
BackgroundInfluentialSelf-citationEvidences for Expression and Location of ANGPTL8 in Human Adipose Tissue
Catalano-Iniesta, L. A., Sánchez‐Robledo, V., Osma, M. D. C. I., Albiñana, A. G., Carrero, S., Blanco, E. J., Carretero‐Hernández, M., Carretero, J., & García‐Barrado, M. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020512 · Cited by 27
“The association of ANGPTL8 with insulin resistance [18,26,27], blood glucose [28,29], C ‐ peptide and glycosylated haemoglobin (HbA1C) have not offered clear results [30].”
BackgroundZhao, Z., Deng, X., Jia, J., Zhao, L., Wang, C., Cai, Z., Guo, C. Y., Yang, L., Wang, D., Ma, S., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154921 · Cited by 26
Self-citationRenal function is independently associated with circulating betatrophin
Maurer, L., Schwarz, F., Fischer‐Rosinsky, A., Schlueter, N., Brachs, S., Möhlig, M., Pfeiffer, A. F. H., Mai, K., Spranger, J., & Bobbert, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173197 · Cited by 26
Ejarque, M., Borlaug, M., Vilarrasa, N., Martinez-Perez, B., Llauradó, G., Megía, A., Helland, T., Gutiérrez, C., Serena, C., Folkestad, O. H., et al. (2017) · Translational research · doi:10.1016/j.trsl.2017.03.001 · Cited by 25
Corrales, E. P., Gómez‐Ambrosi, J., Moncada, R., Valentí, V., Catalán, V., Rodríguez, A., Ramírez, B., Silva, C., Gil, M. J., Salvador, J., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-015-2026-7 · Cited by 24
Qu, Q., Zhao, D., Zhang, F., Bao, H., & Yang, Q. (2017) · Journal of International Medical Research · doi:10.1177/0300060516680441 · Cited by 23
“Betatrophin has recently been introduced as a novel potent stimulator of b-cell replication and improved glucose tolerance by increasing the b-cell division rate in mouse models of insulin resistance.7 There is evidence suggesting that betatrophin expression can be induced by a high-fat diet and insulin, resulting in…”
BackgroundResultInfluentialFadaei, R., Shateri, H., DiStefano, J. K., Moradi, N., Mohammadi, M. R., Emami, F., Aghajani, H., & Ziamajidi, N. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03725-7 · Cited by 23
Meng, X., Li, D., Kan, R., Xiang, Y., Pan, L., Guo, Y., Yu, P., Luo, P., Zou, H., Huang, L. T., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03183-8 · Cited by 22
“We and others have found elevated levels of circulating ANGPTL8 in individuals with diabetes [11, 49].”
BackgroundSelf-citationThe Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer ofβ-Cell Proliferation
Abu‐Farha, M., Madhoun, A. S. A., & Abubaker, J. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4860595 · Cited by 23
“Other studies showed that ANGPTL8 level was increased in T2D as well [64, 67, 68, 70].”
Angiopoietin-like 8 (Angptl8) controls adipocyte lipolysis and phospholipid composition
Mysore, R., Liebisch, G., Zhou, Y., Olkkonen, V. M., & Haridas, P. A. N. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.05.002 · Cited by 21
“Most of the recent studies suggest that plasma ANGPTL8 levels are elevated in type 2 diabetes (T2D), insulin resistance or obesity (Abu-Farha et al., 2016; Chen et al., 2015; Fu et al., 2014).”
BackgroundHigh betatrophin in coronary patients protects from cardiovascular events
Leiherer, A., Ebner, J., Muendlein, A., Brandtner, E. M., Zach, C., Geiger, K. D., Fraunberger, P., & Drexel, H. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.011 · Cited by 24
Zou, H., Xu, Y., Chen, X., Yin, P., Li, D., Li, W., Xie, J., Shao, S., Liu, L., & Yu, X. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01103-7 · Cited by 22
Self-citationGenetic and Metabolic Determinants of Plasma Levels of ANGPTL8
Oldoni, F., Bass, K., Kozlitina, J., Hudson, H., Shihanian, L. M., Gusarova, V., Cohen, J. C., & Hobbs, H. H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab120 · Cited by 21
Liu, J., Yang, K., Xiao, W., Le, Y., Lang, S., Zhang, J., Wei, R., Yang, J., & Hong, T. (2018) · Peptides · doi:10.1016/j.peptides.2018.07.001 · Cited by 20
Self-citationGuo, K., Yu, H., Lu, J., Bao, Y., Chen, H., & Jia, W. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.024 · Cited by 19
“Although the role of betatrophin in β-cell function is still controversial, most clinical studies have found that the betatrophin level was increased significantly in T2D subjects [14-19].”
BackgroundResultPlasma betatrophin levels in patients with liver cirrhosis
Arias, M., García-Unzueta, M. T., Llerena, S., Iruzubieta, P., Puente, A., Cabezas, J., Alonso, C., Cuadrado, A., Amado, J. A., Crespo, J., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10662 · Cited by 20
Zou, H., Wu, D., Zhang, Z., Chen, X., Lu, P., & Yu, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-69091-y · Cited by 19
Self-citationDeischinger, C., Sluková, D., Just, I., Kaufmann, U., Harreiter, J., van Trotsenburg, M., Trattnig, S., Krššák, M., Kautzky‐Willer, A., Klepochová, R., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2123425 · Cited by 19
Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans
Espes, D., Martinell, M., Liljebäck, H., & Carlsson, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0676-4 · Cited by 19
Erol, O. Ö., Özel, M. K., Ellidağ, H. Y., Toptaş, T., Uysal, A., & Yılmaz, N. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1286464 · Cited by 18
Kahraman, S., Altınova, A. E., Yalçın, M. M., Gülbahar, Ö., Arslan, B., Aktürk, M., Cakir, N., & Törüner, F. B. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0831-2 · Cited by 19
Pu, D., Li, L., Jingxia, Y., Liu, R., Yang, G., Liao, Y., & Wu, Q. (2019) · Mediators of Inflammation · doi:10.1155/2019/6321427 · Cited by 17
“Consistent with the current results, previous reports from different groups also showed these correlations between ANGPTL8 and other parameters [28, 29].”
BackgroundResultAlenad, A. M. H., Alenezi, M. M., Alokail, M. S., Wani, K., Mohammed, A. K., Alnaami, A. M., Sulimani, M. M., Zargar, S., Clerici, M., & Al‐Daghri, N. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63850-7 · Cited by 18
Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
Li, M., Fan, R., Peng, X., Huang, J., Zou, H., Yu, X., Yang, Y., Shi, X., & Ma, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.695750 · Cited by 18
“An interesting observation in present study was that, unlike other studies (30, 31), ANGPTL8 correlated directly and significantly with hs-CRP, but not with homeostatic model assessment insulin resistance (HOMA-IR), where there was no such significant correlation.”
ResultSelf-citationÖnalan, E., Bozkurt, A., Gürsu, M. F., Yakar, B., & Dönder, E. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.03.303 · Cited by 16
Huang, Y., Fang, C., Ma, Z., Guo, H., Wang, R., & Hu, J. (2016) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0036-1584566 · Cited by 17
Wang, S., Hong, X., Tu, Z., & Yuan, G. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.025 · Cited by 17
“In a study conducted by Calan et al. a total of 328 women were enrolled, including 164 patients with PCOS and 164 age- and BMI-matched female controls.”
BackgroundInfluentialSelf-citationLi, L., Zhang, F., Cui, J., Shi, Y., Xiang, J., Wang, X., Zhao, N., Yan, Q.-W., Greenberg, A. S., Peng, Y., et al. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1252743 · Cited by 20
Yang, L., Song, J., Zhang, X., Xiao, L., Hu, X., Pan, H., Qin, L., Liu, H., Ge, B., & Zheng, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00414 · Cited by 16
“In newly diagnosed type 2 diabetic patients, Hu et al found that serum ANGPTL8 positively correlated with fasting glucose and 2-h post-OGTT glucose (10), moreover, the results of their study and another research both proved that circulating ANGPTL8 levels were positively associated with indexes of insulin resistance i…”
BackgroundResultIncreased serum levels of betatrophin in pancreatic cancer-associated diabetes
Susanto, H., Liu, T.-Y., Chen, C.-C., Purnomo, J. D. T., Chen, S.-F., & Wang, C.-H. (2016) · Oncotarget · doi:10.18632/oncotarget.9815 · Cited by 15
“com/oncotarget A number of studies have showed that betatrophin levels were correlated with T1D and T2D and increased in T1D and T2D patients [11, 12, 23, 30].”
BackgroundInvestigation of Blood Betatrophin Levels in Obese Children with Non-Alcoholic Fatty Liver Disease
Battal, F., Türkön, H., Aylanç, N., Aylanç, H., Yıldırım, Ş., Kaymaz, N., & Uysal, S. (2018) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2018.21.2.111 · Cited by 15
“Serum betatrophin level was similar in the obese subjects with NAFLD compared to the nonNAFLD group (median, 9 [4-115]; median, 10 [5-116];”
BackgroundZheng, J., Liu, J., Hong, B. S., Ke, W., Huang, M., & Li, Y. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0531-8 · Cited by 18
Navaeian, M., Asadian, S., Ahmadpour Yazdi, H., & Gheibi, N. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06270-8 · Cited by 14
“[54] (2015) ANGPTL8 levels are increased in patients with T2DM Serum 137cont 112 T2DM”
BackgroundEmerging insights into the roles of ANGPTL8 beyond glucose and lipid metabolism
Ye, H., Zong, Q., Zou, H., & Zhang, R. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1275485 · Cited by 15
Adamska, A., Łebkowska, A., Jacewicz‐Święcka, M., Krentowska, A., Hryniewicka, J., Wołczyński, S., Górska, M., & Kowalska, I. (2017) · International Journal of Endocrinology · doi:10.1155/2017/2316986 · Cited by 14
“It has also been observed that serum betatrophin concentration positively correlated with HbA1c and fasting plasma glucose in the group of patients with diabetes, prediabetic state, and metabolic syndrome [19] and with fasting plasma glucose and HOMA-IR in T2D and nondiabetic subjects [20].”
BackgroundResultLuo, D., Chen, X., Yang, W., Ran, W., & Wen, Z. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0725-7897 · Cited by 15
Self-citationRoth, C. L., Elfers, C., Lass, N., & Reinehr, T. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12412 · Cited by 14
Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy
Al-Majed, H. T., Abu‐Farha, M., ALSHAWAF, E. M. M., Devarajan, S., Alsairafi, Z. K., EL-Helaly, A. E., Cherian, P., Al‐Khairi, I., Ali, H., Jose, R. M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814244 · Cited by 13
Xu, J., Lin, Y., Zhou, H. R., Zhao, L., & Xiang, G. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-108911 · Cited by 13
“Upon replacement of partial unadjusted correlation coefficients with the adjusted ones [10, 12, 16, 22, 29], all there-pooled summary estimates remained largely unchanged compared with the primary estimate (r = 0.”
ResultAkdemir, E., Şahin, E., Madendağ, Y., Şahin, M. E., Madendağ, İ. Ç., Açmaz, G., Özdemir, F., Muhtaroğlu, S., & Müderris, İ. İ. (2020) · Placenta · doi:10.1016/j.placenta.2020.07.018 · Cited by 13
ALSHAWAF, E. M. M., Al‐Ozairi, E., Al-Asfar, F., Albeloushi, S., Kumari, S., Tuomilehto, J., & Arefanian, H. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.026 · Cited by 12
Betatrophin expression is promoted in obese hyperinsulinemic type 2 but not type 1 diabetic mice
Li, E., Nakata, M., Shinozaki, A., Yang, Y. K., Zhang, B., & Yada, T. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0164 · Cited by 15
“The type 2 diabetic patients with obesity and insulin resistance showed increased serum betatrophin levels [12].”
BackgroundSelf-citationLee, S., Rhee, M., Kwon, H., Park, Y., & Yoon, K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.53 · Cited by 12
Hou, G., Tang, Y., Ren, L., Guan, Y., Hou, X., & Song, G. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1621239 · Cited by 11
“Related clinical studies have shown that serum ANGPTL8 is associated with diabetes and metabolic syndrome, [22, 35, 36] as well as chronic complications related to diabetes, including diabetic nephropathy and diabetic retinopathy [37, 38].”
BackgroundIncreased circulating full-length betatrophin levels in drug-naïve metabolic syndrome
Liu, D., Li, S., He, H., Yu, C., Li, X., Liang, L., Chen, Y., Li, J., Li, J., Sun, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15102 · Cited by 11
Biological Pathways Leading From ANGPTL8 to Diabetes Mellitus–A Co-expression Network Based Analysis
Siddiqa, A., Cirillo, E., Tareen, S. H. K., Ali, A., Kutmon, M., Eijssen, L., Ahmad, J., Evelo, C. T., & Coort, S. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01841 · Cited by 11
Circulating ANGPTL8 levels and risk of kidney function decline: Results from the 4C Study
Zou, H., Xu, Y., Meng, X., Li, D., Chen, X., Du, T., Yang, Y., Chen, Y., Shao, S., Yuan, G., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01317-3 · Cited by 11
Self-citationBulmuş, F. G., Melekoğlu, R., Gürsu, M. F., Bağcı, H., Kavak, E. Ç., & Akyol, A. (2020) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2020.67026 · Cited by 10
“Chen et al.(22) reported a significant increase in the betatrophin level in patients with type 2 DM, and showed significant correlations between the betatrophin level and insulin resistance indices, including the HOMA-IR score.”
BackgroundANGPTL8 Gene Polymorphism rs2278426 Is Related to Carotid Intima–Media Thickness in T2DM
Guo, C. Y., Zhao, L., Ding, Y., Zhao, Z., Wang, C., Li, L., Cai, Z., Li, Y., Xia, H., Zhu, Z.-Z., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s274759 · Cited by 11
Self-citationSerum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome
Haydardedeoğlu, F. E., Bağır, G. Ş., Haydardedeoğlu, B., Bozkırlı, E., Bakıner, O., Metin, K., & Ertörer, M. E. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1519791 · Cited by 10
“The findings about betatrophin concentrations in obesity, T2DM, and pregnancy are also conflicting [10,28].”
BackgroundZielińska, A., Maciulewski, R., Siewko, K., Popławska‐Kita, A., Lipińska, D., Kozłowska, G., Górska, M., & Szelachowska, M. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.07.029 · Cited by 9
“[5] Chen X, Lu P, He W, Zhang J, Liu L, Yang Y, et al.”
BackgroundEmara, A. M., Bendary, A. S. E., Ahmed, L. M., & Okda, H. I. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03663-2 · Cited by 13
“However, controversial findings were found when Sestrin 2 levels were monitored in obese and/or T2DM patients [12].”
BackgroundInfluentialSönmez, A., Doğru, T., Erçin, C. N., Genç, H., Çelebi, G., Gürel, H., Tapan, S., Çiçek, A. F., Barçın, C., Haymana, C., et al. (2021) · Metabolites · doi:10.3390/metabo11070425 · Cited by 10
Xu, F., Wang, N., Li, G., Tian, D., & Shi, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s330700 · Cited by 9
Decreased circulating levels of ANGPTL8 in Graves’ disease patients
Li, H., Xu, M., Zhao, L., Xia, H., Li, Y., Hong, X., Deng, X., Yuan, J., Ding, Y., Guo, C. Y., et al. (2019) · HORMONES · doi:10.1007/s42000-019-00095-8 · Cited by 10
Self-citationErşahin, A., Acet, M., Erşahin, S. S., Acet, T., Yardım, M., Kenanoglu, O., & Aydın, S. (2017) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2017.44.1.33 · Cited by 9
Fu, C., Oczypok, E. A., Ali, H., DeLany, J. P., Reeves, V. L., Chang, R., & Kershaw, E. E. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.04.006 · Cited by 8
ANGPTL8 in cardio-metabolic diseases
Su, X., Cheng, Y., & Wang, B. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.05.017 · Cited by 8
Self-citationPlasma and aqueous levels of subfatin, preptin and betatrophin in patients with diabetic retinopathy
Kobat, S. G., Gül, F. C., Çelik, F., Uzun, S. L., Kobat, M. A., Akkoç, R. F., & Aydın, S. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-03075-0 · Cited by 7
Zou, H., Li, H., Zhao, Z., Meng, X., Li, D., Chen, X., Guo, Y., Yang, Y., Liu, Z., He, W., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110044 · Cited by 7
Self-citationALSHAWAF, E. M. M., Abu‐Farha, M., Mohammad, A., Devarajan, S., Al‐Khairi, I., Cherian, P., Ali, H., Al-Matrouk, H., Al‐Mulla, F., Alattar, A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12050949 · Cited by 6
Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes
Takebayashi, K., Hara, K., Terasawa, T., Naruse, R., Suetsugu, M., Tsuchiya, T., & Inukai, T. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3114w · Cited by 7
“However, some recent studies show positive association of circulating betatrophin levels with markers of glycemic control in patients with type 2 diabetes [9-11], although the association is not investigated fully in poorly controlled type 2 diabetes with the mean hemoglobin (Hb) A1c levels over 10%.”
BackgroundResultInfluentialÖzyazgan, S., Önal, B., Kurtuluş, E. M., Uzun, H., Akkan, G., & Konukoğlu, D. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-104383 · Cited by 6
Bayat, M., Alaee, M., Akbari, A., Sadegh, M., Latifi, S. A., Parastesh, M., Salehi, M., Karami, H., & Amri, J. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0046 · Cited by 6
Angiopoietin-like 8 governs osteoblast-adipocyte lineage commitment during skeletal aging
Guo, Y., Zhang, Z., He, J., Luo, P., Wang, Z., Zhu, Y., Meng, X., Pan, L., Kan, R., Xiang, Y., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.189371 · Cited by 5
“…protein 8 (ANGPTL8), also referred to as betatrophin, is an adipokine with essential functions in inflammation and is associated with metabolic and aging-related disorders such as obesity, diabetes (11), hypothyroidism, nonalcoholic steatohepatitis (12), and polycystic ovary syndrome (13, 14).”
Self-citationPérez-López, F. R., Yuan, J., Prieto, M. S., López-Baena, M. T., Pérez‐Roncero, G. R., & Varikasuvu, S. R. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3612 · Cited by 5
Upadhyay, K. K., Du, X., Chen, Y., Buscher, B., Chen, V. L., Oliveri, A., Zhao, R., Speliotes, E. K., & Brady, G. F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.036 · Cited by 6
Metadata
- Authors
- Chen, X., Lu, P., He, W., Zhang, J., Liu, L., Yang, Y., Liu, Z., Xie, J., Shao, S., Du, T., Su, X., Zhou, X., Hu, S., Yuan, G., Zhang, M., Zhang, H., Liu, L., Wang, D., & Yu, X.
- Affiliations
- Tongji Hospital (CN)
- Corresponding author
- Yu, Xuefeng
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-01
- Volume
- 100
- Issue
- 1
- Pages
- E96-E100
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2141915302
- Cited by
- 129
- References
- 18
- Citations by year
- 2025: 7 · 2024: 7 · 2023: 6 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 7 · 2018: 14 · 2017: 18 · 2016: 21 · 2015: 13
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- betatrophin, type 2 diabetes, insulin resistance, impaired fasting glucose, impaired glucose tolerance, glucose tolerance, insulin sensitivity index, beta cell regeneration, circulating biomarkers
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Longitudinal Studies, Male, Middle Aged, Prediabetic State, Glucose Intolerance, Peptide Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.